Lack of elevations in glucocorticoids correlates with dysphoria-like behavior after repeated social defeat

Physiology and Behavior

Volumn 105, Issue 4, 2012, Pages 958-965

  Bowens, Nicole ^a   Heydendael, Willem ^b   Bhatnagar, Seema ^b   Jacobson, Lauren ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Depression; Glucocorticoid; Glucocorticoid receptor; Habituation; Mineralocorticoid receptor; Post traumatic stress disorder

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; PROTEIN C FOS; STEROID 11BETA MONOOXYGENASE;

ADRENAL CORTEX; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DYSPHORIA; FEMALE; GENE EXPRESSION; HIPPOCAMPAL CA2 REGION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; SOCIAL DISABILITY;

ADRENAL GLANDS; ANHEDONIA; ANIMALS; ANXIETY; CA2 REGION, HIPPOCAMPAL; CORTICOSTERONE; DEPRESSION; DISEASE MODELS, ANIMAL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, INBRED C57BL; MOLECULAR IMAGING; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, MINERALOCORTICOID; SEPTUM OF BRAIN; SOCIAL BEHAVIOR; STEROID 11-BETA-HYDROXYLASE; STRESS, PSYCHOLOGICAL;

EID: 82655186624     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.10.032     Document Type: Article

References (52)

1. Gold P.W., Gabry K.E., Yasuda M., Chrousos G.P. Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiological implications. Endocrinol Metab Clin North Am 2002, 31:37-62.
2. Rapaport M. Translating the evidence on atypical depression into clinical practice. J Clin Psychiatry 2007, 68(Suppl. 3):31-36.
3. Trivedi M.H., Hollander E., Nutt D., Blier P. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression. J Clin Psychiatry 2008, 61:9-15.
4. Ising M., Horstmann S., Kloiber S., Lucae S., Binder E.B., Kern N., et al. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?. Biol Psychiatry 2007, 62:47-54.
5. Jacobson L. Hypothalamic-pituitary-adrenocortical axis regulation. Endocrinol Metab Clin North Am 2005, 34:271-292.
6. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
7. Balbo M., Leproult R., Cauter E.V. Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity. Int J Endocrinol 2010, 2010. Article ID 759234.
8. Rush A.J., Giles D.E., Schlesser M.A., Orsulak P.J., Parker C.R., Weissenburger J.E., et al. The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry 1996, 57:470-484.
9. Anacker C., Zunszain P.A., Carvalho L.A., Pariante C.M. The glucocorticoid receptor: pivot of depression and of antidepressant treatment?. Psychoneuroendocrinology 2011, 36:415-425.
10. Bouwer C., Claassen J., Dinan T.G., Nemeroff C.B. Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series. Depress Anxiety 2000, 12:44-50.
11. Kier A., Han J., Jacobson L. Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression. Endocrinology 2005, 146:1338-1347.
12. Stewart J.W., McGrath P.J., Quitkin F.M., Klein D.F. DSM-IV depression with atypical features: is it valid?. Neuropsychopharmacology 2009, 34:2625-2632.
13. Davidson J.R.T. A history of the concept of atypical depression. J Clin Psychiatry 2007, 38(Suppl. 3):10-15.
14. Stewart J.W., Quitkin F.M., McGrath P.J., Klein D.F. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions. J Affective Disord 2005, 86:161-167.
15. Levitan R.D., Vaccarino F.J., Brown G.M., Kennedy S.H. Low-dose dexamethasone challenge in women with atypical major depression: pilot study. J Psychiatry Neurosci 2002, 27:47-51.
16. Stewart J.W., McGrath P.J., Quitkin F.M. Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?. Neuropsychopharmacology 2002, 26:237-245.
17. Stewart J.W. Treating depression with atypical features. J Clin Psychiatry 2007, 68(Suppl. 3):25-29.
18. Tamashiro K.L.K., Nguyen M.M.N., Sakai R.R. Social stress: from rodents to primates. Front Neuroendocrinology 2005, 26:27-40.
19. Albeck D.A., McKittrick C.R., Blanchard D.C., Blanchard R.J., Nikulina J., McEwen B.S., et al. Chronic social stress alters levels of corticotropin-releasing factor and arginine vasopressin mRNA in rat brain. J Neurosci 1997, 17:4895-4903.
20. Lutter M., Krishnan V., Russo S.J., Jung S., McClung C.A., Nestler E.J. Orexin signaling mediates the antidepressant-like effect of calorie restriction. J Neurosci 2008, 28:3071-3075.
21. Jacobson L. CRH and NPY are not decreased in hypophagic, protein-deprived rats. Peptides 2000, 21:1487-1493.
22. Heydendael W., Jacobson L. Widespread hypothalamic-pituitary-adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice. Eur J Neurosci 2010, 31:892-902.
23. vanBeveren C., Straaten Fv, Curran T., Muller R., Verma I.M. Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell 1983, 32:1241-1255.
24. Domalik L.J., Chaplin D.D., Kirkman M.S., Wu R.C., Liu W., Howard T.A., et al. Different isozymes of mouse 11beta-hydroxylase produce mineralocorticoids and glucocorticoids. Mol Endocrinol 1991, 5:1853-1861.
25. Heydendael W., Jacobson L. Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response. Brain Res 2008, 1238:93-107.
26. Weintraub A., Singaravelu J., Bhatnagar S. Enduring and sex-specific effects of adolescent social isolation in rats on adult stress reactivity. Brain Res 2010, 1343:83-92.
27. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005, 29:571-625.
28. Miyata K., Kamato T., Nishida A., Ito H., Yuki H., Yamano M., et al. Role of the serotonin3 receptor in stress-induced defecation. J Pharmacol Exp Ther 1992, 261:297-303.
29. Katz R.J. Animal model of depression: pharmacological sensitivity of hedonic deficit. Pharmacol Biochem Behav 1982, 16:965-968.
30. Levin N., Shinsako J., Dallman M.F. Corticosterone acts on the brain to inhibit adrenalectomy-induced adrenocorticotropin secretion. Endocrinology 1988, 122:694-701.
31. Heydendael W., Jacobson L. Glucocorticoid status affects antidepressant regulation of locus coeruleus tyrosine hydroxylase and dorsal raphé tryptophan hydroxylase gene expression. Brain Res 2009, 1288:69-78.
32. Radley J.J., Arias C.M., Sawchenko P.E. Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress. J Neurosci 2006, 26:12967-12976.
33. Weinberg M.S., Johnson D.C., Bhatt A.P., Spencer R.L. Medial prefrontal cortex activity can disrupt the expression of stress response habituation. Neuroscience 2010, 168:744-756.
34. Bhatnagar S., Huber R., Nowak N., Trotter P. Lesions of the posterior paraventricular thalamus block habituation of hypothalamic-pituitary-adrenal responses to repeated restraint. J Neuroendocrinol 2002, 14:403-410.
35. Davis J.F., Krause E.G., Melhorn S.J., Sakai R.R., Benoit S.C. Dominant rats are natural risk takers and display increased motivation for food reward. Neuroscience 2009, 162:23-30.
36. Herman J.P., Adams D., Prewitt C. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 1995, 61:180-190.
37. Boyle M.P., Kolber B.J., Vogt S.K., Wozniak D.F., Muglia L.J. Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness. J Neurosci 2006, 26:1971-1978.
38. Swiergiel A.H., Leskow I.L., Dunn A.J. Effects of chronic and acute stressors and CRF on depression-like behavior in mice. Behav Brain Res 2008, 186:32-40.
39. VanDijken H.H., Mos J., VanderHeyden A.M., Tilders F.J.H. Characterization of stress-induced long-term behavioral changes in rats: evidence in favor of anxiety. Physiol Behav 1992, 52:945-951.
40. Kinsey S.G., Bailey M.T., Sheridan J.F., Padgett D.A., Avitsur R. Repeated social defeat causes increased anxiety-like behavior and alters splenocyte function in C57BL/6 and CD-1 mice. Brain Behav Immun 2007, 21:458-466.
41. Walsh R.N., Cummins R.A. The open-field test: a critical review. Pscyhol Bull 1976, 83:482-504.
42. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131:391-404.
43. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 1998, 43:547-573.
44. Kollack-Walker S., Don C., Watson S.J., Akil H. Differential expression of c-fos mRNA within neurocircuits of male hamsters exposed to acute or chronic defeat. J Neuroendocrinol 1999, 11:547-559.
45. Wood S.K., Walker H.E., Valentino R.J., Bhatnagar S. Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factor. Endocrinology 2010, 151:1795-1805.
46. Grissom N., Bhatnagar S. Habituation to repeated stress: get used to it. Neurobiol Learn Mem 2009, 92:215-224.
47. Kc P., Dick T.E. Modulation of cardiorespiratory function mediated by the paraventricular nucleus. Respir Physiol Neurobiol 2010, 174:55-64.
48. Thase M.E. Recognition and diagnosis of atypical depression. J Clin Psychiatry 2007, 68(Suppl. 8):11-16.
49. Cohen H., Zohar J., Gidron Y., Matar M.A., Belkind D., Loewenthal U., et al. Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats. Biol Psychiatry 2006, 59:1208-1218.
50. Aerni A., Traber R., Hock C., Roozendaal B., Schelling G., Papassotiropoulos A., et al. Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry 2004, 161:1488-1490.
51. Matza L.S., Revicki D.A., Davidson J.R., Stewart J.W. Depression with atypical features in the national comorbidity study. Arch Gen Psychiatry 2003, 60:817-826.
52. Yehuda R. Risk and resilience in posttraumatic stress disorder. J Clin Psychiatry 2004, 65(Suppl. 1):29-36.